KATHRYN RUSHAK: Open Payments
NPI 1538512033 · BINGHAMTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 71 payments from 33 companies in 2025. Trend: 2023 $1,109 · 2024 $1,231 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $204 |
| PFIZER INC. | 7 | $109 |
| Eisai Inc. | 3 | $94 |
| ABBVIE INC. | 4 | $85 |
| ARRAY BIOPHARMA INC | 4 | $81 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Incyte Corporation | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Daiichi Sankyo Inc. | 2 | $57 |
Products named: Lenvima, LUTATHERA, KISQALI, LORBRENA, KEYTRUDA, NINLARO, EPKINLY, OPDIVO.
Industry payments across NY — which companies pay providers there.
